Literature DB >> 29315674

Is miR-21 a potent target for liver fibrosis?

Sanchuan Lai1, Yasuko Iwakiri1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29315674      PMCID： PMC5992001          DOI： 10.1002/hep.29774

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  10 in total

Review 1.  A framework for understanding the roles of miRNAs in animal development.

Authors:  Chiara Alberti; Luisa Cochella
Journal:  Development       Date:  2017-07-15       Impact factor: 6.868

2.  MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis.

Authors:  Jorge Matias Caviglia; Jun Yan; Myoung-Kuk Jang; Geum-Youn Gwak; Silvia Affo; Lexing Yu; Peter Olinga; Richard A Friedman; Xin Chen; Robert F Schwabe
Journal:  Hepatology       Date:  2018-01-18       Impact factor: 17.425

Review 3.  Roles for microRNAs in conferring robustness to biological processes.

Authors:  Margaret S Ebert; Phillip A Sharp
Journal:  Cell       Date:  2012-04-27       Impact factor: 41.582

4.  miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells.

Authors:  Jing Zhang; Jingjing Jiao; Silvia Cermelli; Kyle Muir; Kwang Hwa Jung; Ruhai Zou; Asif Rashid; Mihai Gagea; Sonya Zabludoff; Raghu Kalluri; Laura Beretta
Journal:  Cancer Res       Date:  2015-03-13       Impact factor: 12.701

5.  The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development.

Authors:  Zhengping Zhang; Yinhe Zha; Wei Hu; Zhen Huang; Zhongfei Gao; Yuhui Zang; Jiangning Chen; Lei Dong; Junfeng Zhang
Journal:  J Biol Chem       Date:  2013-11-06       Impact factor: 5.157

6.  A catalog of the mouse gut metagenome.

Authors:  Liang Xiao; Qiang Feng; Suisha Liang; Si Brask Sonne; Zhongkui Xia; Xinmin Qiu; Xiaoping Li; Hua Long; Jianfeng Zhang; Dongya Zhang; Chuan Liu; Zhiwei Fang; Joyce Chou; Jacob Glanville; Qin Hao; Dorota Kotowska; Camilla Colding; Tine Rask Licht; Donghai Wu; Jun Yu; Joseph Jao Yiu Sung; Qiaoyi Liang; Junhua Li; Huijue Jia; Zhou Lan; Valentina Tremaroli; Piotr Dworzynski; H Bjørn Nielsen; Fredrik Bäckhed; Joël Doré; Emmanuelle Le Chatelier; S Dusko Ehrlich; John C Lin; Manimozhiyan Arumugam; Jun Wang; Lise Madsen; Karsten Kristiansen
Journal:  Nat Biotechnol       Date:  2015-09-28       Impact factor: 54.908

7.  Inhibiting miR-21 attenuates experimental hepatic fibrosis by suppressing both the ERK1 pathway in HSC and hepatocyte EMT.

Authors:  Kaiming Wu; Changhong Ye; Lin Lin; Yimin Chu; Meng Ji; Weiping Dai; Xin Zeng; Yong Lin
Journal:  Clin Sci (Lond)       Date:  2016-05-25       Impact factor: 6.124

Review 8.  Microbiota, cirrhosis, and the emerging oral-gut-liver axis.

Authors:  Chathur Acharya; Sinem Esra Sahingur; Jasmohan S Bajaj
Journal:  JCI Insight       Date:  2017-10-05

9.  Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice.

Authors:  Lindsey L Kennedy; Fanyin Meng; Julie K Venter; Tianhao Zhou; Walker A Karstens; Laura A Hargrove; Nan Wu; Konstantina Kyritsi; John Greene; Pietro Invernizzi; Francesca Bernuzzi; Shannon S Glaser; Heather L Francis; Gianfranco Alpini
Journal:  Lab Invest       Date:  2016-10-24       Impact factor: 5.662

10.  miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice.

Authors:  Pedro M Rodrigues; Marta B Afonso; André L Simão; Catarina C Carvalho; Alexandre Trindade; António Duarte; Pedro M Borralho; Mariana V Machado; Helena Cortez-Pinto; Cecília Mp Rodrigues; Rui E Castro
Journal:  Cell Death Dis       Date:  2017-05-25       Impact factor: 8.469
  10 in total
  6 in total

1.  Longitudinal analysis of serum microRNAs as predictors of cirrhosis regression during treatment of hepatitis B virus infection.

Authors:  Cody Orr; Rob Myers; Biao Li; Zhaoshi Jiang; John Flaherty; Anuj Gaggar; Eric G Meissner
Journal:  Liver Int       Date:  2020-05-02       Impact factor: 5.828

Review 2.  The role of MicroRNAs in tendon injury, repair, and related tissue engineering.

Authors:  Qian Liu; Yaxi Zhu; Weihong Zhu; Ge Zhang; Yunzhi Peter Yang; Chunfeng Zhao
Journal:  Biomaterials       Date:  2021-08-26       Impact factor: 15.304

3.  Delivery of microRNA-21-sponge and pre-microRNA-122 by MS2 virus-like particles to therapeutically target hepatocellular carcinoma cells.

Authors:  Jiawei Zhang; Dandan Li; Rui Zhang; Rongxue Peng; Jinming Li
Journal:  Exp Biol Med (Maywood)       Date:  2021-10-13

4.  Extracellular vesicles derived from umbilical cord mesenchymal stromal cells alleviate pulmonary fibrosis by means of transforming growth factor-β signaling inhibition.

Authors:  Liyan Shi; Jing Ren; Jiping Li; Dongxu Wang; Yusu Wang; Tao Qin; Xiuying Li; Guokun Zhang; Chunyi Li; Yimin Wang
Journal:  Stem Cell Res Ther       Date:  2021-04-12       Impact factor: 6.832

5.  Inhibition of miR-21 alleviated cardiac perivascular fibrosis via repressing EndMT in T1DM.

Authors:  Qianqian Li; Yufeng Yao; Shumei Shi; Mengchen Zhou; Yingchao Zhou; Mengru Wang; Jeng-Jiann Chiu; Zhengrong Huang; Weili Zhang; Min Liu; Qing Wang; Xin Tu
Journal:  J Cell Mol Med       Date:  2019-11-03       Impact factor: 5.310

Review 6.  Serum non-coding RNAs for diagnosis and stage of liver fibrosis.

Authors:  Chao Liu; Xueyun Hou; Kaixin Mo; Nannan Li; Cheng An; Guijian Liu; Zongdai Pan
Journal:  J Clin Lab Anal       Date:  2022-08-21       Impact factor: 3.124
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.